4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-23-016933
Executive Vice President & CFO acquired 45,289 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Konidaris Tasos Executive Vice President & CFO | 2023-03-03 | Option exercise | +45,289 | 293,121 | D | ||
| Derivatives | |||||||
| Konidaris Tasos Executive Vice President & CFO | 2023-03-03 | Option exercise · Restricted Stock Units | −45,289 | 135,870 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2023-03-03 | Grant or award · Restricted Stock Units | +229,358 | 229,358 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2023-03-03 | Grant or award · Performance-Based Restricted Stock Units | +458,716 | 458,716 | D | ||
Loading xslF345X03/doc4.xml…